Related Experiment Video
Updated: Aug 1, 2026

Implantation and Recording of Wireless Electroretinogram and Visual Evoked Potential in Conscious Rats
Published on: June 29, 2016
Epinephrine absorption from commercial gingival retraction cords in clinical patients
S A Kellam1, J R Smith, S J Scheffel
1Department of Physiology and Pharmacology, Oregon Health Sciences University, School of Dentistry, Portland.
Abstract:
Absorption of epinephrine from commercial gingival retraction cords was measured in vivo under clinical conditions. The amount of epinephrine absorbed was estimated by measurement with fluorospectrophotometry of the amount of dl-epinephrine remaining in the cords after they were removed and subtracting this value from the dl-epinephrine concentration in matching control cords. All cords lost substantial amounts of epinephrine while in the sulcus, with individual losses ranging from 64% to 94%. An average 71 micrograms of l-epinephrine was absorbed per inch of two-ply cord, and extreme variability in the dl-epinephrine concentration for individual segments of commercial cord was noted. In addition, the cords did not contain the concentration of epinephrine (500 micrograms/inch) listed on the package label but instead had a mean dl-epinephrine concentration of 225.5 micrograms/inch.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Local Anesthetics: Pharmacokinetics
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Ophthalmic Drug Delivery Systems
Cardiopulmonary Resuscitation IV: Pharmacological Management

